Roche Diagnostics Operations, Inc. recalls cobas HCYS
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
- Products
-
- cobas HCYS
- Where it was sold
-
US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,
States: Florida, Iowa, Indiana, New Jersey, New York, Oklahoma, South Carolina, Texas
- Barcodes
04015630929979- Units affected
- 458 units
- About this recall
- cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine